I

InteKrin Therapeutics Inc.

10 employees

InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.

Basic info

Sectors

Biotechnology
Neuroscience
Therapeutics

Date founded

2014

Funding rounds raised

Total raised

$23M

from 19 investors over 19 rounds

I

InteKrin Therapeutics Inc. raised $2.3M on June 14, 2010

Investors: Asset Management Company

I

InteKrin Therapeutics Inc. raised $21M on April 2, 2009

Investors: Asset Management Company

I

InteKrin Therapeutics Inc. raised $19M on August 4, 2008

Investors: Sears Capital Management Inc, Sky Ventures, Sofinnova Ventures, Russia technology fund, Asset Management Company, Asset Management Ventures, Vivo Capital and OrbiMed Advisors

I

InteKrin Therapeutics Inc. raised $533K on February 15, 2008

Investors: Asset Management Company

I

InteKrin Therapeutics Inc. raised $181K on September 21, 2007

Investors: Asset Management Company

I

InteKrin Therapeutics Inc. raised $23M on January 12, 2007

Investors: Sears Capital Management Inc, Vivo Capital, Sofinnova Ventures, Russia technology fund, Asset Management Ventures, Asset Management Company and OrbiMed Advisors

I

InteKrin Therapeutics Inc. raised $450K on September 22, 2006

Investors: Valterna AG

I

InteKrin Therapeutics Inc. raised $75K on January 15, 2006

Investors: Asset Management Company

FAQ